Beef Magazine is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.



(OMAHA, Neb.) The success of the CLAAS JAGUAR forage harvester reaches another milestone with the production of the 25,000th commemorative edition JAGUAR 980 delivered to Gene and Curt Stoll (Stoll Brothers) in Oconto Falls, Wisconsin. Presented with the signature of Chairman, Dr. Helmut Claas, this JAGUAR is truly a historic machine.

Production of this “signature” edition was finalized in late February at the CLAAS headquarters in Harsewinkel, Germany. It then climbed aboard the cargo ship departing Germany and reached the port of Baltimore, MD on May 10th.

The JAGUAR was loaded for transport to its final destination and entered the field on May 24th.

“It’s been quite a journey for our new JAGUAR,” explained Curt, “and it’s been well worth the wait. We started with the CLAAS JAGUAR 820 in 1988, then moved up to an 860, then to a 900 and now with our new JAGUAR 980, owning a commemorative CLAAS forage harvester means even more to us.”

Eugene Stoll stated, “We harvest 6,000 acres of hay and corn and the JAGUAR has never let us down. The JAGUAR has improved our operation right from the beginning (ten years ago). The precise quality of the chop, speed and technology behind this machine, lets us know that our continued dedication to CLAAS is the right decision.”

The first JAGUAR rolled off the production line in June 1973 and CLAAS began to create a foothold in the market as a premier manufacturer of self-propelled forage harvesters. Continuing to mark its success, the JAGUAR series became a formidable industry benchmark satisfying market demand for a higher quality chop, reliability, controlled-power when

you need it most and fine-tuned agility in the field.

Bob Armstrong, North American Product Marketing Manager stated, “The growth we’ve achieved since the production of the 10,000th JAGUAR in 1994 through the production of the 25,000th commemorative machine today showcases our engineering “know-how”. The process we use to develop and deliver the market’s leading forage harvester is simple: Listen, Develop, Refine and Repeat. Our relationship with the customer and dealer is what counts and this partnership makes handing over the keys to Gene and Curt such an privilege.”

The Stoll Brothers will make the special edition JAGUAR 980 available for viewing at Wisconsin Farm Technology Days, July 15-17 at the CLAAS of America exhibit. “This has really just been an unbelievable ride with CLAAS,” Curt concluded.

CLAAS of America, Inc. offers a wide variety of technologically innovative hay tool, baler and self-propelled forage harvester and combine harvester products to provide growers optimum performance in the field. These products are designed by a dedicated engineering staff located at three different worldwide factories focused on the production and design of harvesting equipment. The design, performance and reliability of this equipment have made CLAAS an international market leader. For more information, visit


CLAAS of America Inc.

P.O. Box 45031

Omaha, NE 68145-0031

Phone: 402-861-1000

Fax: 402-861-1003

Press Release



For more information on the delivery of the CLAAS 25,000th JAGUAR, visit the pressroom at

to download high-resolution photos.

Company: CLAAS of America

Contact: Bob Armstrong

Product Marketing Manager

(402) 861-1000

[email protected]


Protect Calves With The Highest Level of BVD PI Prevention Available

NEW YORK (June 17, 2008) – Cattle producers can use the first and only vaccine available that prevents persistently infected (PI) calves caused by bovine viral diarrhea (BVD) virus Types 1 and 2, and offers 365 days of protection – Bovi-Shield GOLD® FP®. The USDA recently upgraded the label claim for Bovi-Shield GOLD FP to the “prevention of persistently infected calves caused by BVD Types 1 and 2,” which is the highest label claim the USDA has assigned to a BVD-containing vaccine.

The cost of BVD to beef and dairy producers with PI calves ranges from $15 to $31 per cow.1,2 Although more than 50 percent of the PI calves usually do not survive past 12 months of age, some survive to reproductive maturity and appear completely normal.3 These PI calves shed the BVD virus in large amounts throughout their lives, infecting other animals that come into contact with them. This is especially critical in breeding herds where PI animals, especially calves, spread the virus to susceptible females, potentially resulting in the birth of more PI calves the next year.

“Knowing the level of protection of a reproductive vaccine is important in managing the risk of disease in your herd,” says Dale Grotelueschen, DVM, managing veterinarian with Pfizer Animal Health. “Preventing the birth of PI calves is a key component of BVD control.”

A PI calf results from BVD virus exposure in utero about 40 to 120 days into gestation. During this critical exposure period, infection can occur before the calf’s immune system is sufficiently developed to initiate a protective response. Therefore, BVD is not recognized as an infecting virus. As the immune system matures, it perceives the virus as part of the calf itself and will not develop an effective immune response against it.

“Preventing PI during this critical exposure period requires a vaccine with sufficient duration of immunity (DOI),” says Grotelueschen, “which is the time period immunity stimulated by the vaccine is effective against a specific disease.”

To compare the duration of immunity of five-way viral vaccines, visit Here you can use the calculator to determine if your vaccine is protecting your herd during the time of critical exposure for BVD persistent infection.

“I often hear that vaccines are all the same and that it doesn’t matter which one is used,” Grotelueschen adds. “Well-tested products like Bovi-Shield GOLD FP have clear advantages over other BVD vaccines that don’t have supporting research for reproductive protection claims.”


Know Your Vaccine’s Level of Protection

The decision about which type of label claim a vaccine will be granted is based on an evaluation by the Center for Veterinary Biologics, which is part of the Animal and Plant Inspections Service at the USDA. After evaluating vaccine efficacy data, the USDA assigns each product a level of protection based on how the vaccine is expected to perform. The five possible USDA label claims are:4

1. Prevention of infection – the highest granted by USDA, it can only be made if a product can prevent all colonization or replication of the challenge organism in vaccinated and challenged animals.

2. Prevention of disease – intended for products that are highly effective in preventing clinical disease in vaccinated and challenged animals.

3. Aids in disease prevention – the most common label claim for vaccines on the market today. The product has shown that it prevents disease in vaccinated and challenged animals by a clinically significant amount that may be less than that required to support a “prevention of disease” claim.

4. Aids in disease control – the product aids in the reduction of disease severity or duration, or delays onset.

5. Other claims – these products have beneficial effects other than direct disease control, such as the control of infection through the reduction of shedding of the organism.

According to USDA label indication guidelines, all vaccines must include the level of protection information on the label. Look for it the next time you buy a vaccine, and talk to your veterinarian to determine which vaccine is right for your operation.

Pfizer Inc. (NYSE: PFE), the world’s largest research-based pharmaceutical company, is a world leader in discovering and developing innovative animal vaccines and prescription medicines. Pfizer Animal Health is dedicated to improving the safety, quality and productivity of the world’s food supply by enhancing the health of livestock and poultry; and in helping companion animals live longer and healthier lives. For additional information on Pfizer’s portfolio of animal products, visit


LABEL INDICATIONS: The Bovi-Shield GOLD line and PregGuard® GOLD FP 10 are recommended for vaccination of healthy cows and heifers approximately 1 month prior to breeding. These products can also be administered to pregnant cattle provided they were vaccinated, according to label directions, with any Bovi-Shield FP or PregGuard FP vaccine prior to breeding initially and within 12 months thereafter. Failure to follow label directions may result in abortions. The Bovi-Shield GOLD line may be administered to calves nursing pregnant cows, provided their dams were vaccinated within the last 12 months as described above. Consistent with good vaccination practices, heifers should receive at least 2 vaccine doses, with the second dose administered approximately 30 days pre-breeding.

1 Larson RL, Pierce VL, Grotelueschen DM, Wittum TE. Economic evaluation of beef cowherd screening for cattle persistently infected with bovine viral diarrhea virus. Bov Pract 2002;36(2):106-112.

2 Chi J, VanLeeuwen JA, Weersink A, Keefe GP. Direct production losses and treatment costs from bovine viral diarrhea virus, bovine leukosis virus, Mycobacterium avium subspecies paraturberculosis and Neospora caninum. Prev Vet Med 2002;55(2):137-153.

3 Duffell SJ, Harkness JW. Bovine virus diarrhoea-mucosal disease infection in cattle. Vet Rec. 1985 Sep 7;117(10):240-245.

4 Veterinary Services Memorandum No. 800.82, June 14, 2002.

Bovi-Shield, Bovi-Shield GOLD, FP and PregGuard are registered trademarks of Pfizer Inc. ©2008 Pfizer Inc. All rights reserved. BSD08016

Pfizer Inc. . 150 East 42nd Street . New York, NY 10017

212-733-2323 .

For further information, contact:

Jennie Schutte

Pfizer Animal Health


[email protected]

Kenna Rathai



[email protected]


Gerard Davis Named Head of Product Development and Laboratory Operations at Pfizer Animal Genetics

NEW YORK (June 17, 2008)

Highly respected genetic researcher Gerard Davis has been named Head of Product Development and Laboratory Operations at Pfizer Animal Genetics. Dr. Davis will have global responsibilities for research and development of all new products in the Pfizer Animal Genetics portfolio.

"Gerard brings a strong background in genomics research, as well as the foresight to identify and develop the next generations of products our customers demand," says Nigel Evans, vice president of Animal Genetics for Pfizer Animal Health. "His relevant research in beef genomic technologies, as well as the experience gained from co-founding and building a solid and successful genomics company, Genetic Solutions/Catapult Genetics, will be invaluable as we create and develop a market-leading portfolio of DNA marker-based products."

Prior to joining Pfizer Animal Genetics, Gerard Davis served as chief executive office of Catapult Genetics Pty. Ltd., which resulted from a merger in December 2006 between Genetic Solutions (co-founded in 1998 by Davis and Jay Hetzel) and Catapult Global. In this position he was responsible for research and development of the company's product portfolio, as well as overall business development.

Previously, Davis was employed by Australia's Commonwealth Scientific and Industrial Research Organization, a major research establishment focused on livestock genetics research. He also spent time as a visiting professor at Colorado State University, where he worked on genotype environment interaction in beef cattle and molecular aspects of quantitative genetics.

Davis obtained a Bachelor of Applied Science degree from the University of New South Wales and in 1998 received his Ph.D. from the University of New England. He completed his MBA degree in 2000 at Queensland University of Technology and is also a graduate member of the Australian Institute of Company Directors.

Pfizer Animal Genetics is a business unit of Pfizer Animal Health, a world leader in discovering and developing innovative animal vaccines and prescription medicines. Pfizer Inc. is the world's largest research-based pharmaceutical company.


Pfizer Animal Genetics

150 East 42nd Street

New York, NY 10017

For further information, contact:

Doug Ricke

Director of Marketing

(212) 733-7420

[email protected]


Mike Opperman

Charleston|Orwig, Inc.


[email protected]


Limousin Trends Favorable for Scrotal Circumference, Docility, Carcass Traits

Cattle producers can accomplish significant genetic improvement in a short period when using effective selection tools, such as expected progeny differences (EPDs), to deal with moderately heritable traits. The Limousin breed’s phenotypic trends in scrotal circumference (SC), docility and carcass traits illustrate that fact.

“Based on documented phenotypic trends, Limousin breeders are using selection and management effectively to produce seedstock with improved performance profiles,” said Kent Andersen, Ph.D., executive vice president for the North American Limousin Foundation (NALF). “Commercial users of Limousin genetics are the beneficiaries of those breed improvements.”

From 1997 to 2007, Limousin phenotypic trends showed a 2.0-centimeter increase in adjusted yearling SC, on average, for Limousin and Lim-Flex® bulls. Based on research, producers also can expect an associated improvement in age at puberty in the bulls’ heifer contemporaries.

Similarly, average recorded docility scores indicated an improvement of 0.25 score unit across both sexes over those 10 years, a time frame that coincides with NALF’s genetic evaluation for docility. Limousin breeders have been using docility EPDs in their breeding programs to emphasize selection for calmer animals, and they have improved the temperament of Limousin cattle dramatically.

NALF also studied the trends in yearling-adjusted ultrasound measurements for ribeye area (REA), percent intramuscular fat (IMF, an indicator of marbling) and subcutaneous rib fat. While documenting phenotypic stability for the breed’s industry-leading REA, the organization found encouraging increases in IMF. Bulls improved 0.20 percentage point, while females were up 0.33 percentage point.

The additional 0.06 inch of observed subcutaneous rib fat in both sexes indicates earlier compositional maturity and increased fleshing ability. Those are economically desirable for female adaptability and days on feed for finishing, especially during times of particularity high feed costs, Andersen noted.

The North American Limousin Foundation (, headquartered in Centennial, Colo., provides programs and services – including genetic evaluation of 5,000 active sires – to more than 4,000 members and their commercial customers. The Limousin breed and its

Lim-Flex® hybrid lead the beef industry in muscle-growth efficiency and ideally complement British breeds.

For immediate release

Contact Brad Parker

June 17, 2008

[email protected]


Pfizer Animal Genetics Expands Commitment to Genetic Progress

via Bovine Carcass Merit Project

HARTLAND, Wis. (June 13, 2008) The opportunity for beef producers to satisfy consumer demand for consistent, high-quality beef may be closer to reality through the Carcass Merit Project (CMP). Following its acquisition of Bovigen, the original commercial sponsor, Pfizer Animal Genetics is now collaborating on the project with a group of universities led by Texas A&M University. The project, which includes data contributed by 14 breed associations, is coordinated by the National Cattlemen's Beef Association (NCBA) and primarily funded by Beef Checkoff Program dollars.

The CMP was created with the ultimate goal of identifying and commercializing genetic markers associated with improved meat quality, resulting in greater consumer satisfaction and enhanced producer profitability through the development of higher-value beef.

"The CMP is one of the most important projects undertaken by the beef industry in recent years," said Dr. David Lunt, Professor, Associate Head of Operations, and McGregor Research Center Superintendent at Texas A&M University. "The outcomes of this project will make possible over time basic changes to the genetic base of beef cattle in the United States with the specific target of improving producers' ability to meet consumer demands for product satisfaction."

Gene marker technology identifies animals with superior carcass traits prior to harvest. Since heritable traits are permanent, these genetic traits can be passed on to future generations creating offspring with enhanced carcass quality. Over time this will help enhance product consistency and increase the opportunity for consumers to have a positive eating experience with a high-quality, tender product.

"Over the last decade the beef industry has increasingly focused on providing the most palatable and economical product possible to our customers, the beef consumer," says NCBA Senior Vice President of Research, Education and Innovation Bo Reagan. "Much of this work has focused on postharvest technologies. This project, however, focuses on how we can make at least as much progress toward addressing consumer demands by improving the genetics within the industry."

Commenting on project progress, Calvin Gunter, Director of Corporate Development with Pfizer Animal Genetics, says "Our scientists have conducted an initial analysis of associations between genotypic and phenotypic information in the CMP data base. Now, with the added resources of Pfizer Animal Health, we expect to move quickly toward identifying and validating valuable new marker panels for key carcass traits."

Pfizer Animal Genetics is completely invested in and committed to the cattle genetics industry, says Nigel Evans, Vice President, Animal Genetics for Pfizer Animal Health. We are dedicated to accelerating the delivery of new genetic tools based on the CMP program. These technologies will enable producers to capture higher profits from higher-value carcasses, and help meet consumer demand for high-quality, tender and flavorful beef on the dinner table.

Pfizer Animal Genetics is a business unit of Pfizer Animal Health, a world leader in discovering and developing innovative animal vaccines and prescription medicines. Pfizer Inc. is the world's largest research-based pharmaceutical company.

Pfizer Animal Genetics

150 East 42nd Street

New York, NY 10017

For further information, contact:

Doug Ricke

Director of Marketing

(212) 733-7420

[email protected]


Mike Opperman

Charleston|Orwig, Inc.


[email protected]

Corn Hits $7; Ethanol Apologists Grow More Shrill

The corn market trended higher this week with December corn flirting with the $7/bu. level this week. In addition, USDA lowered its expected yield by 5 bu./acre to 148.9, a significant reduction this early in the year.

Rain makes grain, they say, but too much moisture in the Corn Belt has delayed both planting and emergence, even flooding some fields. We’re approaching the trigger time when some some ground will be shifted out of corn.

While there’s been a lot of talk about a global food crisis, and increasing concerns about the subsidization of ethanol, it’s hard to fathom any substantive change in the ethanol policy. That means we’ll come out of this year with even lower ending stocks than a year ago, which would be the lowest level in more than a decade. However, there was good news this week with reports of production increases in China and Russia, and good prospects for the second corn crop in Brazil.

In looking back at market reports from a year ago, I noticed everyone was talking about the implications of $3.50/bu. corn. Who would have thought that we’d be talking double that price today?

My frequent rants about ethanol’s impacts on the cattle industry has gotten me added to the list for mailings from ethanol-industry apologists. It’s interesting that as the opposition to the ethanol giveaways becomes louder, the claims of the ethanol apologists become more shrill. In fact, I had to smile at the one this week asserting that corn prices would barely fall if the ethanol subsidies were ended today. If nothing else that should put a smile on your face during a difficult time.

Beef Irradiation’s Time Is Now

As one of the few public health professionals who has taken a strong, public stance in favor of food irradiation, I agree with Iowa State University’s Dennis Olson that the public health community needs to exercise stronger leadership in support of irradiation (“Whatever Happened To Irradiation?” May 2 BEEF Cow-Calf Weekly).

However, the introduction of public health standards that we take for granted today – iodinization of salt, fluoridation of water, mandatory vaccinations for school attendance and, yes, pasteurization of milk – were not accomplished overnight. Despite advocacy beginning early in the 20th century, Minnesota did not require pasteurization until 1948.

The time for mandatory irradiation of ground beef and other high-risk foods, like lettuce and tomatoes, is coming. The case gets stronger with each new outbreak. In fact, a new E.coli O157:H7 outbreak in romaine lettuce was reported in Washington state last week, and the Food and Drug Administration had just advised restaurant chains to stop serving tomatoes because of an outbreak in 16 states traced to raw tomatoes.

Mandatory irradiation will come sooner if beef producers accept that irradiation is in their best interests. Are the costs of outbreaks – lost sales, lawsuits and recalls – really a necessary part of doing business? Are you at risk of losing your business if an outbreak is traced back to your establishment?

The bottom line for me though, is whether it would be acceptable for your child to end up on kidney dialysis in the hospital with hemolytic-uremic syndrome. Let's all get moving together on using irradiation to make ground beef even safer!

Wyoming Range Monitoring Workshop Is June 23

Ranchers, landowners, range managers and others are invited to participate in a June 23 range-monitoring workshop near Lander, WY. Attendees will learn range-monitoring techniques; how to identify grasses, forbs and shrubs; and tour riparian and upland sites in the Bureau of Land Management’s Atlantic City Common Allotment.

"We’ll be teaching range-monitoring methods that are simple and easy to learn yet are still scientifically valid and approved by federal land management agencies,” says Barton Stam, University of Wyoming Cooperative Extension Service (UW CES) educator.

Participants should meet at the Atlantic City Mercantile in Atlantic City south of Lander at 10 a.m., bringing their own lunch and drinking water. The workshop is free. For more info, contact Stam at 307-864-3421.

Will the Market Ration Corn Use?

It hasn’t yet, but it’s not out of the question, says Gregg Doud, National Cattlemen’s Beef Association chief economist. And if it happens, it’s likely that cattlemen will bear the brunt.

Cattlemen operate in an inelastic market, he says, meaning that in the short term, the producer pays the price when there’s no replacement for a commodity such as corn. Feedyards are currently losing $100 million/week in equity on fed cattle, he says. “When the banker tells that feedlot that it’s over, what’s going to happen? We contract.” And at some point in time, he adds, the red ink running in the feedyard sector will flow into the laps of the cow-calf producer.

In the long term, however, it’s the consumer who ultimately pays because economic forces cause the industry to shrink and prices to go up. “If you think we have food inflation now, we’re just getting warmed up,” he says.

Whole Foods To Buy Beef Despite Conflict

Country Natural Beef producers will continue to have access to Whole Foods customers, the grocery chain announced this week.

Last week, Whole Foods announced it would stop buying beef from Beef Northwest feedyard, located at Boardman, OR, because of an effort by United Farm Workers to unionize the operation (“Union Targets Oregon Feedlot; Whole Foods Caves,” June 6 BEEF Cow-Calf Weekly). Because Country Natural Beef cattle are finished at the feedyard, the announcement effectively blocked the flow of product to retail customers.

However, Whole Foods reversed its stance this week and said it will continue to buy Country Natural Beef from the feedyard despite the efforts by union activists. Whole Foods is Country Natural Beef’s biggest customer, making up 70% of the co-op’s business.

Whole Foods spokeswoman Libba Letton said many Whole Foods customers felt the chain’s actions were a sign of support for UFW. “We heard a lot from our customers that they believed that it was a sign that we weren’t supporting Country Natural Beef, which our customers are a very big fan of.”